Genetic susceptibility to acquired long QT syndrome: Pharmacologic challenge in first-degree relatives
- 28 February 2005
- journal article
- Published by Elsevier BV in Heart Rhythm
- Vol. 2 (2), 134-140
- https://doi.org/10.1016/j.hrthm.2004.10.039
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Drug-Induced Prolongation of the QT IntervalNew England Journal of Medicine, 2004
- Genetic variations of KCNQ1, KCNH2, SCN5A, KCNE1 , and KCNE2 in drug-induced long QT syndrome patientsJournal of Molecular Medicine, 2004
- T wave peak-to-end interval and QT dispersion in acquired long QT syndrome: a new index for arrhythmogenicityClinical Science, 2003
- Effect of amiodarone on the descending limb of the T waveThe American Journal of Cardiology, 2003
- Sex differences in the rate dependence of the T wave descending limb.Cardiovascular Research, 2003
- Sotalol testing unmasks altered repolarization in patients with suspected acquired long-QT-syndrome?a case-control pilot study using i.v. sotalolEuropean Heart Journal, 2003
- Variant of SCN5A Sodium Channel Implicated in Risk of Cardiac ArrhythmiaScience, 2002
- Cellular Basis for Complex T Waves and Arrhythmic Activity Following Combined IKr and IKs BlockJournal of Cardiovascular Electrophysiology, 2001
- Long QT syndromes and torsade de pointesThe Lancet, 1999
- Sodium Channel Block With Mexiletine Is Effective in Reducing Dispersion of Repolarization and Preventing Torsade de Pointes in LQT2 and LQT3 Models of the Long-QT SyndromeCirculation, 1997